Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.22 trillion and total revenue of $110.07 billion.
Market Cap
1.22T
Revenue
110.07B
Profits
-40.31B
PE Ratio
n/a
Profit Margin
-36.62%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 124.36B | -0.08% | 372,544 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 70.81B | 0.12% | 455,980 | 14.92B |
| 3 | ARGX | argenx SE | 55.20B | 0.70% | 148,022 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 38.69B | -1.01% | 724,411 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.14B | -0.94% | 485,354 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 36.30B | -1.18% | 100,929 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 34.50B | -0.09% | 1,240,666 | 2.44B |
| 8 | INCY | Incyte Corporation | 25.87B | -1.77% | 1,220,992 | 5.82B |
| 9 | ROIV | Roivant Sciences Ltd. | 23.79B | -2.28% | 1,685,489 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.62B | 1.03% | 326,505 | 3.23B |
| 11 | INSM | Insmed Incorporated | 22.48B | -0.40% | 926,124 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 21.70B | -2.00% | 2,398,548 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.45B | -1.41% | 545,257 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.74B | -0.20% | 306,776 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.57B | -1.20% | 1,282,173 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 16.14B | 0.01% | 164,838 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.06B | -1.04% | 537,919 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.45B | 0.26% | 122,316 | 1.13B |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.98B | -0.82% | 878,667 | 622.01M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.89B | -0.89% | 496,908 | 3.24B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.80B | -2.09% | 213,628 | 708.24M |
| 22 | TECH | Bio-Techne Corporation | 11.25B | 0.17% | 3,121,283 | 1.21B |
| 23 | KRYS | Krystal Biotech, Inc. | 10.70B | -0.35% | 145,628 | 417.30M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.69B | -1.39% | 365,122 | 5.67M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.68B | -0.98% | 848,642 | 105.82M |
| 26 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.02% | 387,426 | - |
| 27 | CORT | Corcept Therapeutics Incorporated | 10.00B | -1.06% | 455,306 | 769.10M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 9.86B | -0.37% | 607,838 | 1.51B |
| 29 | SMMT | Summit Therapeutics Inc. | 9.84B | -1.67% | 1,612,225 | - |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 9.01B | -1.46% | 1,409,611 | 873.71M |
| 31 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.10% | 1,064,181 | 18.07M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 8.71B | -0.20% | 224,454 | 51.48M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 8.59B | -2.34% | 141,458 | 74.06M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.52B | -3.03% | 689,939 | - |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.12B | -1.52% | 177,535 | 7.46M |
| 36 | IMVT | Immunovant, Inc. | 7.94B | -1.13% | 869,764 | - |
| 37 | PCVX | Vaxcyte, Inc. | 7.69B | -2.42% | 553,586 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.64B | -1.73% | 1,380,316 | 700.35M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.39B | -0.13% | 161,013 | 217.17M |
| 40 | IBRX | ImmunityBio, Inc. | 7.14B | -2.15% | 4,887,223 | 140.98M |
| 41 | COGT | Cogent Biosciences, Inc. | 6.76B | -2.75% | 391,537 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.71B | -1.98% | 305,759 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 6.17B | -1.30% | 300,408 | 827.11M |
| 44 | XENE | Xenon Pharmaceuticals Inc. | 6.17B | -1.69% | 229,500 | 7.50M |
| 45 | CGON | CG Oncology, Inc. | 6.12B | -4.41% | 529,630 | 5.07M |
| 46 | ERAS | Erasca, Inc. | 6.08B | -3.58% | 1,964,144 | - |
| 47 | BLTE | Belite Bio, Inc | 5.98B | -2.53% | 154,759 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.89B | -0.46% | 444,360 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.72B | -2.54% | 168,431 | 274.48M |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 5.60B | 0.88% | 312,539 | 1.34M |
| 51 | DFTX | Definium Therapeutics, Inc. | 5.57B | -0.02% | 873,943 | - |
| 52 | TVTX | Travere Therapeutics, Inc. | 5.27B | 1.38% | 493,299 | 536.20M |
| 53 | ORKA | Oruka Therapeutics, Inc. | 5.18B | -5.07% | 430,923 | - |
| 54 | MANE | Veradermics, Incorporated | 4.71B | 1.11% | 210,524 | - |
| 55 | DYN | Dyne Therapeutics, Inc. | 4.66B | -3.63% | 1,046,358 | - |
| 56 | CRSP | CRISPR Therapeutics AG | 4.63B | -1.16% | 690,350 | 4.10M |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 4.48B | 0.54% | 516,566 | 1.10B |
| 58 | CAI | Caris Life Sciences, Inc. | 4.32B | -2.05% | 1,649,413 | 907.29M |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -1.66% | 259,199 | - |
| 60 | PBLS | Parabilis Medicines, Inc. | 4.07B | 0.03% | 122,600 | - |
| 61 | CELC | Celcuity Inc. | 4.03B | 0.12% | 600,420 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.98B | -0.05% | 726,786 | 10.68M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.85B | -2.13% | 1,257,130 | - |
| 64 | DNLI | Denali Therapeutics Inc. | 3.78B | -1.00% | 635,821 | - |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.75B | -2.81% | 1,007,063 | 56.99M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.72B | -0.97% | 198,427 | - |
| 67 | LEGN | Legend Biotech Corporation | 3.64B | -1.08% | 1,209,729 | 1.14B |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 3.49B | -1.90% | 475,118 | 415.62M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.44B | -0.83% | 34,778 | 803.79M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | -0.58% | 452,828 | 225.27M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.39B | -0.27% | 234,206 | - |
| 72 | ALMS | Alumis Inc. | 3.35B | -2.92% | 480,766 | 8.40M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.31B | -2.59% | 325,928 | 236.00M |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.22B | -1.64% | 440,160 | 22.57M |
| 75 | MBX | MBX Biosciences, Inc. | 3.04B | 6.28% | 235,487 | - |
| 76 | CLDX | Celldex Therapeutics, Inc. | 2.88B | 3.12% | 540,171 | 865.00K |
| 77 | IRON | Disc Medicine, Inc. | 2.80B | -1.71% | 168,524 | - |
| 78 | QURE | uniQure N.V. | 2.77B | 9.79% | 2,211,768 | 18.67M |
| 79 | ATAI | AtaiBeckley Inc. | 2.65B | -0.07% | 9,841,877 | 3.49M |
| 80 | IMNM | Immunome, Inc. | 2.65B | 0.65% | 327,436 | 4.02M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.62B | 0.29% | 725,264 | 164.01M |
| 82 | TRVI | Trevi Therapeutics, Inc. | 2.57B | -1.79% | 502,993 | - |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 2.49B | -2.00% | 219,973 | 535.08M |
| 84 | RARE | Ultragenyx Pharmaceutical Inc. | 2.48B | -2.96% | 375,038 | 670.00M |
| 85 | KOD | Kodiak Sciences Inc. | 2.46B | -2.02% | 253,106 | - |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.44B | -2.61% | 539,412 | 36.77M |
| 87 | VCEL | Vericel Corporation | 2.36B | -1.13% | 151,706 | 292.09M |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.36B | -0.74% | 184,562 | - |
| 89 | VERA | Vera Therapeutics, Inc. | 2.34B | -2.28% | 686,916 | - |
| 90 | NKTR | Nektar Therapeutics | 2.33B | -2.50% | 283,730 | 55.63M |
| 91 | PHVS | Pharvaris N.V. | 2.30B | -2.17% | 145,266 | - |
| 92 | NUVB | Nuvation Bio Inc. | 2.28B | -2.32% | 3,200,760 | 143.05M |
| 93 | KLRA | Kailera Therapeutics, Inc. | 2.18B | 0.72% | 266,709 | - |
| 94 | VRDN | Viridian Therapeutics, Inc. | 2.15B | -0.26% | 555,483 | 70.92M |
| 95 | COAG | Hemab Therapeutics Holdings, Inc. | 2.13B | -3.58% | 328,366 | - |
| 96 | AGIO | Agios Pharmaceuticals, Inc. | 2.09B | -2.58% | 564,230 | 66.05M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.07B | - | 136,763 | 899.11M |
| 98 | IOVA | Iovance Biotherapeutics, Inc. | 2.07B | -1.38% | 6,158,934 | 285.61M |
| 99 | SION | Sionna Therapeutics, Inc. | 2.07B | -1.61% | 110,443 | - |
| 100 | ZLAB | Zai Lab Limited | 2.06B | -1.72% | 270,877 | 453.28M |
| 101 | BHVN | Biohaven Ltd. | 2.04B | -1.45% | 492,882 | - |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.04B | -0.61% | 57,277 | - |
| 103 | ADMA | ADMA Biologics, Inc. | 2.03B | -0.34% | 940,040 | 509.86M |
| 104 | SLS | SELLAS Life Sciences Group, Inc. | 2.02B | 1.68% | 3,072,773 | - |
| 105 | RAPP | Rapport Therapeutics, Inc. | 1.99B | -0.98% | 134,082 | 20.00M |
| 106 | URGN | UroGen Pharma Ltd. | 1.97B | -0.93% | 141,511 | 140.49M |
| 107 | PGEN | Precigen, Inc. | 1.97B | -0.18% | 1,315,249 | 31.60M |
| 108 | ZBIO | Zenas BioPharma, Inc. | 1.95B | -4.58% | 314,691 | 10.00M |
| 109 | GHRS | GH Research PLC | 1.94B | 1.18% | 95,528 | - |
| 110 | AUPH | Aurinia Pharmaceuticals Inc. | 1.93B | 0.53% | 392,636 | 298.30M |
| 111 | FTRE | Fortrea Holdings Inc. | 1.91B | -2.25% | 1,551,209 | 2.68B |
| 112 | NBTX | Nanobiotix S.A. | 1.90B | -1.89% | 83,936 | 38.27M |
| 113 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.13% | 5,387,774 | - |
| 114 | MESO | Mesoblast Limited | 1.85B | -1.66% | 91,981 | 65.38M |
| 115 | OCUL | Ocular Therapeutix, Inc. | 1.85B | - | 683,193 | 52.04M |
| 116 | GLUE | Monte Rosa Therapeutics, Inc. | 1.84B | -1.13% | 424,914 | 42.95M |
| 117 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -1.33% | 136,619 | 1.20B |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.84B | -0.02% | 240,129 | - |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.80B | -1.43% | 157,764 | 32.08M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.80B | -0.68% | 84,147 | - |
| 121 | KARD | Kardigan, Inc. | 1.78B | -4.81% | 80,777 | - |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.77B | 1.19% | 809,630 | 7.47M |
| 123 | BCAX | Bicara Therapeutics Inc. | 1.72B | -2.36% | 169,040 | - |
| 124 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.71B | -3.50% | 1,005,444 | 204.73M |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.71B | -1.78% | 643,649 | 217.17M |
| 126 | GENB | Generate Biomedicines, Inc. | 1.70B | 0.84% | 376,206 | 30.30M |
| 127 | IMCR | Immunocore Holdings plc | 1.69B | -0.78% | 85,873 | 412.81M |
| 128 | AAPG | Ascentage Pharma Group International | 1.67B | 0.08% | 3,954 | 82.08M |
| 129 | ABCL | AbCellera Biologics Inc. | 1.67B | 3.40% | 3,975,680 | 79.21M |
| 130 | SRPT | Sarepta Therapeutics, Inc. | 1.65B | 1.56% | 1,233,820 | 2.18B |
| 131 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | -1.48% | 9,336,253 | 66.41M |
| 132 | INVA | Innoviva, Inc. | 1.59B | -1.35% | 197,675 | 420.69M |
| 133 | ZYME | Zymeworks Inc. | 1.57B | -2.83% | 145,332 | 81.26M |
| 134 | ANAB | AnaptysBio, Inc. | 1.54B | -0.13% | 184,813 | 232.39M |
| 135 | SEPN | Septerna, Inc. | 1.54B | 0.40% | 61,476 | 72.26M |
| 136 | MLTX | MoonLake Immunotherapeutics | 1.53B | -0.75% | 328,232 | - |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.51B | -2.08% | 139,132 | 20.00M |
| 138 | NTLA | Intellia Therapeutics, Inc. | 1.51B | -0.73% | 1,554,779 | 66.09M |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.49B | 1.74% | 167,308 | - |
| 140 | VIR | Vir Biotechnology, Inc. | 1.46B | -2.37% | 407,759 | 65.50M |
| 141 | XNCR | Xencor, Inc. | 1.45B | -1.85% | 367,760 | 97.36M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.38B | -1.17% | 99,704 | - |
| 143 | SVRA | Savara Inc. | 1.34B | -0.84% | 594,155 | - |
| 144 | AKTS | Aktis Oncology, Inc. | 1.28B | 0.63% | 144,948 | 8.28M |
| 145 | ARDX | Ardelyx, Inc. | 1.25B | -0.88% | 774,826 | 427.68M |
| 146 | NVAX | Novavax, Inc. | 1.21B | -0.20% | 1,152,624 | 596.34M |
| 147 | AVLN | Avalyn Pharma Inc. | 1.20B | -2.20% | 34,562 | - |
| 148 | MNKD | MannKind Corporation | 1.20B | -0.26% | 1,549,222 | 360.78M |
| 149 | IMTX | Immatics N.V. | 1.20B | 0.29% | 179,721 | 43.00M |
| 150 | ORIC | ORIC Pharmaceuticals, Inc. | 1.19B | -3.36% | 896,139 | - |
| 151 | INBX | Inhibrx Biosciences, Inc. | 1.16B | -1.17% | 90,155 | 1.30M |
| 152 | ABSI | Absci Corporation | 1.15B | -4.49% | 1,853,123 | 1.84M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.14B | -2.44% | 164,804 | - |
| 154 | WVE | Wave Life Sciences Ltd. | 1.11B | -2.12% | 1,167,523 | 71.80M |
| 155 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -1.28% | 299,787 | - |
| 156 | LBRX | LB Pharmaceuticals Inc | 1.08B | 7.90% | 320,223 | - |
| 157 | VOR | Vor Biopharma Inc. | 1.08B | -0.55% | 438,038 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.08B | -1.78% | 234,670 | 79.76M |
| 159 | IVA | Inventiva S.A. | 1.06B | -0.54% | 897,591 | 7.94M |
| 160 | ANRO | Alto Neuroscience, Inc. | 1.05B | -1.29% | 120,005 | - |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.04B | -2.72% | 224,604 | - |
| 162 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | - | 1,460,475 | 69.64M |
| 163 | SPTX | Seaport Therapeutics, Inc. | 1.04B | -2.54% | 24,416 | - |
| 164 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -2.51% | 309,359 | 59.00K |
| 165 | DRTS | Alpha Tau Medical Ltd. | 998.10M | -4.33% | 434,233 | - |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 988.77M | -2.58% | 282,847 | - |
| 167 | EYPT | EyePoint, Inc. | 983.46M | -1.92% | 774,471 | 7.61M |
| 168 | PHAT | Phathom Pharmaceuticals, Inc. | 932.51M | 0.69% | 260,322 | 204.89M |
| 169 | SANA | Sana Biotechnology, Inc. | 923.69M | -6.38% | 1,502,674 | - |
| 170 | GERN | Geron Corporation | 920.58M | -1.03% | 2,155,622 | 196.12M |
| 171 | JANX | Janux Therapeutics, Inc. | 907.14M | -0.83% | 225,630 | 13.73M |
| 172 | PHAR | Pharming Group N.V. | 885.23M | 0.38% | 2,436 | 369.49M |
| 173 | TBPH | Theravance Biopharma, Inc. | 874.86M | -0.06% | 130,661 | 109.78M |
| 174 | ODTX | Odyssey Therapeutics, Inc. | 862.76M | -2.22% | 90,336 | 1.06M |
| 175 | ABUS | Arbutus Biopharma Corporation | 846.45M | -2.83% | 1,300,934 | 191.45M |
| 176 | OMER | Omeros Corporation | 834.49M | 2.22% | 926,468 | 9.89M |
| 177 | KURA | Kura Oncology, Inc. | 801.63M | -3.01% | 634,944 | 71.64M |
| 178 | DBVT | DBV Technologies S.A. | 799.81M | 0.07% | 169,308 | 5.04M |
| 179 | SLDB | Solid Biosciences Inc. | 799.41M | 1.88% | 316,381 | - |
| 180 | ANNX | Annexon, Inc. | 796.27M | -2.21% | 1,682,192 | - |
| 181 | TENX | Tenax Therapeutics, Inc. | 778.64M | -3.54% | 961,036 | - |
| 182 | AURA | Aura Biosciences, Inc. | 767.68M | -1.28% | 228,513 | - |
| 183 | DSGN | Design Therapeutics, Inc. | 750.11M | 1.18% | 227,792 | - |
| 184 | FTH | Faeth Therapeutics, Inc. | 748.36M | -0.34% | 144,740 | - |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 725.84M | 1.90% | 66,385 | 299.77M |
| 186 | SGP | SpyGlass Pharma, Inc. | 720.82M | -0.28% | 54,214 | - |
| 187 | MNPR | Monopar Therapeutics Inc. | 718.31M | -1.71% | 183,250 | - |
| 188 | ACRS | Aclaris Therapeutics, Inc. | 711.59M | -4.41% | 421,845 | 8.37M |
| 189 | DRUG | Bright Minds Biosciences Inc. | 704.79M | -3.02% | 157,433 | - |
| 190 | CLYM | Climb Bio, Inc. | 703.73M | - | 421,080 | - |
| 191 | CTMX | CytomX Therapeutics, Inc. | 694.47M | -0.93% | 491,006 | 35.54M |
| 192 | CADL | Candel Therapeutics, Inc. | 690.21M | -2.69% | 676,727 | - |
| 193 | MPLT | MapLight Therapeutics, Inc. | 683.81M | 22.50% | 2,091,344 | - |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 665.69M | -3.26% | 145,541 | - |
| 195 | OCS | Oculis Holding AG | 655.21M | -1.85% | 62,547 | 1.40M |
| 196 | NGNE | Neurogene Inc. | 654.40M | -1.14% | 48,855 | 925.00K |
| 197 | MDXG | MiMedx Group, Inc. | 650.89M | 0.23% | 386,639 | 389.42M |
| 198 | NVCT | Nuvectis Pharma, Inc. | 649.43M | 3.94% | 172,071 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 641.06M | -4.01% | 38,463 | 117.05M |
| 200 | ACHV | Achieve Life Sciences, Inc. | 635.46M | 0.16% | 658,670 | - |
| 201 | CBIO | Crescent Biopharma, Inc. | 627.30M | -7.66% | 147,697 | 11.88M |
| 202 | AGMB | AgomAb Therapeutics NV | 625.45M | 1.28% | 30,893 | - |
| 203 | ALLO | Allogene Therapeutics, Inc. | 616.10M | 7.53% | 6,503,500 | 22.00K |
| 204 | RGNX | REGENXBIO Inc. | 593.58M | 0.21% | 384,428 | 87.82M |
| 205 | IMMX | Immix Biopharma, Inc. | 588.74M | -2.01% | 827,169 | - |
| 206 | ALT | Altimmune, Inc. | 582.45M | 0.17% | 2,880,525 | 36.00K |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 576.96M | 0.31% | 444,666 | 122.29M |
| 208 | SPRY | ARS Pharmaceuticals, Inc. | 574.97M | 2.12% | 4,901,959 | 98.99M |
| 209 | CRMD | CorMedix Inc. | 564.07M | -2.18% | 520,859 | 400.05M |
| 210 | RLMD | Relmada Therapeutics, Inc. | 541.23M | -1.34% | 501,720 | - |
| 211 | PRME | Prime Medicine, Inc. | 540.05M | -3.24% | 846,301 | 4.03M |
| 212 | SLN | Silence Therapeutics plc | 538.47M | -1.30% | 190,825 | 839.00K |
| 213 | CTNM | Contineum Therapeutics, Inc. | 533.32M | 0.74% | 57,309 | - |
| 214 | TECX | Tectonic Therapeutic, Inc. | 532.58M | -5.29% | 62,196 | - |
| 215 | ARVN | Arvinas, Inc. | 529.72M | 0.12% | 425,802 | 89.40M |
| 216 | VSTM | Verastem, Inc. | 527.68M | -3.61% | 988,878 | 49.59M |
| 217 | STTK | Shattuck Labs, Inc. | 518.36M | -0.88% | 246,898 | 1.00M |
| 218 | ZURA | Zura Bio Limited | 511.09M | -2.89% | 195,575 | - |
| 219 | EIKN | Eikon Therapeutics, Inc. | 505.11M | -1.69% | 115,220 | - |
| 220 | ANL | Adlai Nortye Ltd. | 504.40M | -0.63% | 40,793 | 5.00M |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 501.85M | -2.54% | 197,189 | 88.24M |
| 222 | HELP | Cybin Inc. | 499.28M | 5.99% | 1,142,114 | - |
| 223 | DNA | Ginkgo Bioworks Holdings, Inc. | 499.08M | -0.78% | 333,125 | 151.40M |
| 224 | ARTV | Artiva Biotherapeutics, Inc. | 496.33M | -2.99% | 188,578 | 251.00K |
| 225 | RZLT | Rezolute, Inc. | 494.13M | -3.86% | 335,894 | - |
| 226 | ASMB | Assembly Biosciences, Inc. | 480.60M | -2.37% | 50,780 | 71.10M |
| 227 | VALN | Valneva SE | 473.69M | -0.59% | 1,380 | 180.25M |
| 228 | PROK | ProKidney Corp. | 463.66M | -0.32% | 331,076 | 889.00K |
| 229 | PRLD | Prelude Therapeutics Incorporated | 452.25M | -1.72% | 221,160 | 16.72M |
| 230 | REPL | Replimune Group, Inc. | 449.21M | - | 6,843,208 | - |
| 231 | PRTA | Prothena Corporation plc | 440.81M | -1.64% | 301,833 | 57.94M |
| 232 | SGMT | Sagimet Biosciences Inc. | 438.44M | -2.34% | 176,609 | - |
| 233 | IKT | Inhibikase Therapeutics, Inc. | 437.75M | -3.03% | 316,676 | 1.00 |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 431.04M | -5.34% | 566,977 | - |
| 235 | CABA | Cabaletta Bio, Inc. | 430.46M | -3.30% | 1,053,491 | - |
| 236 | OVID | Ovid Therapeutics Inc. | 425.54M | -3.39% | 239,522 | 7.12M |
| 237 | SLBT | SL Science Holding Limited | 425.07M | -4.36% | 40,493 | 3.36M |
| 238 | BNTC | Benitec Biopharma Inc. | 412.25M | 0.93% | 17,570 | - |
| 239 | EVMN | Evommune, Inc. | 403.59M | -0.40% | 150,764 | 10.00M |
| 240 | PBYI | Puma Biotechnology, Inc. | 400.58M | -1.25% | 67,441 | 227.18M |
| 241 | OCGN | Ocugen, Inc. | 397.76M | -5.24% | 4,214,265 | 4.47M |
| 242 | EPRX | Eupraxia Pharmaceuticals Inc. | 396.40M | 0.33% | 594,493 | - |
| 243 | EDIT | Editas Medicine, Inc. | 392.86M | -2.29% | 707,364 | 38.69M |
| 244 | CCCC | C4 Therapeutics, Inc. | 391.41M | -0.28% | 1,006,281 | 34.86M |
| 245 | VTVT | vTv Therapeutics Inc. | 387.30M | 0.42% | 172,788 | 36.84M |
| 246 | CAPR | Capricor Therapeutics, Inc. | 385.11M | 1.22% | 27,501 | 11.13M |
| 247 | STRO | Sutro Biopharma, Inc. | 384.27M | -2.28% | 79,296 | 99.61M |
| 248 | LRMR | Larimar Therapeutics, Inc. | 382.04M | -4.44% | 831,268 | - |
| 249 | AUTL | Autolus Therapeutics plc | 377.92M | -2.07% | 258,262 | 92.62M |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 372.56M | 0.51% | 511,538 | 9.01M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 372.13M | 3.10% | 276,884 | - |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 364.64M | -0.56% | 54,745 | 69.21M |
| 253 | IPSC | Century Therapeutics, Inc. | 364.32M | -1.46% | 627,337 | 109.16M |
| 254 | CMPX | Compass Therapeutics, Inc. | 358.37M | -2.45% | 2,044,959 | 850.00K |
| 255 | DMAC | DiaMedica Therapeutics Inc. | 349.70M | -2.26% | 130,901 | - |
| 256 | ABEO | Abeona Therapeutics Inc. | 345.39M | 0.66% | 642,717 | 14.54M |
| 257 | UPB | Upstream Bio, Inc. | 341.76M | -1.88% | 241,551 | 3.32M |
| 258 | SCTX | Scribe Therapeutics Inc. | 341.54M | 0.25% | 166,252 | 36.28M |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 340.77M | -1.31% | 27,390 | 51.00M |
| 260 | PALI | Palisade Bio, Inc. | 337.61M | -3.71% | 893,900 | - |
| 261 | CUVL | Clinuvel Pharmaceuticals Limited | 337.43M | - | 6 | 64.24M |
| 262 | RCKT | Rocket Pharmaceuticals, Inc. | 337.41M | -1.59% | 568,462 | - |
| 263 | LXEO | Lexeo Therapeutics, Inc. | 335.29M | -2.73% | 367,724 | - |
| 264 | ZNTL | Zentalis Pharmaceuticals, Inc. | 329.59M | 0.22% | 344,783 | 26.87M |
| 265 | VCRE | Vicore Pharma Holding AB (publ) | 321.73M | -10.99% | 1,069 | 370.61K |
| 266 | LYEL | Lyell Immunopharma, Inc. | 321.01M | 0.85% | 67,096 | 31.00K |
| 267 | NMRA | Neumora Therapeutics, Inc. | 306.65M | -1.49% | 232,577 | - |
| 268 | AGEN | Agenus Inc. | 306.11M | 3.64% | 996,456 | 123.87M |
| 269 | VNDA | Vanda Pharmaceuticals Inc. | 299.48M | -3.49% | 305,588 | 217.78M |
| 270 | OABI | OmniAb, Inc. | 284.87M | -0.25% | 138,857 | 28.94M |
| 271 | FHTX | Foghorn Therapeutics Inc. | 279.48M | -7.21% | 88,125 | 28.22M |
| 272 | IRD | Opus Genetics, Inc. | 278.25M | -1.17% | 347,014 | 11.98M |
| 273 | SLGL | Sol-Gel Technologies Ltd. | 272.67M | 0.41% | 26,215 | 18.47M |
| 274 | FATE | Fate Therapeutics, Inc. | 270.42M | - | 513,549 | 6.32M |
| 275 | BCYC | Bicycle Therapeutics plc | 270.17M | -1.78% | 210,645 | 63.50M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 267.62M | 1.45% | 183,856 | 114.70K |
| 277 | IMRX | Immuneering Corporation | 262.02M | -4.48% | 503,484 | - |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 261.28M | -0.59% | 613,708 | - |
| 279 | ALXO | ALX Oncology Holdings Inc. | 261.05M | -2.51% | 195,714 | - |
| 280 | LCTX | Lineage Cell Therapeutics, Inc. | 258.02M | -3.27% | 762,980 | 14.78M |
| 281 | QTTB | Q32 Bio Inc. | 256.21M | -3.82% | 306,926 | 53.74M |
| 282 | ADAG | Adagene Inc. | 253.42M | 2.83% | 303,194 | 7.67M |
| 283 | NAGE | Niagen Bioscience, Inc. | 252.60M | -3.80% | 377,494 | 130.42M |
| 284 | PRQR | ProQR Therapeutics N.V. | 246.82M | -0.62% | 133,878 | 15.73M |
| 285 | IFRX | InflaRx N.V. | 246.72M | -0.89% | 430,541 | 33.82K |
| 286 | FULC | Fulcrum Therapeutics, Inc. | 246.21M | -0.67% | 398,701 | 80.00M |
| 287 | MGNX | MacroGenics, Inc. | 236.14M | -3.51% | 153,209 | 157.08M |
| 288 | OBIO | Orchestra BioMed Holdings, Inc. | 232.34M | 0.52% | 132,609 | 32.72M |
| 289 | AVXL | Anavex Life Sciences Corp. | 231.22M | -2.92% | 624,543 | - |
| 290 | TRDA | Entrada Therapeutics, Inc. | 228.81M | 8.92% | 161,126 | 5.74M |
| 291 | GALT | Galectin Therapeutics Inc. | 227.70M | 1.99% | 193,778 | - |
| 292 | TTRX | Turn Therapeutics Inc. | 225.35M | -1.75% | 46,712 | - |
| 293 | ACIU | AC Immune SA | 224.69M | -2.37% | 25,879 | 4.62M |
| 294 | INDP | Indaptus Therapeutics, Inc. | 218.56M | 11.56% | 107,114 | - |
| 295 | CHRS | Coherus Oncology, Inc. | 216.72M | -2.43% | 274,201 | 46.88M |
| 296 | SRZN | Surrozen, Inc. | 216.36M | -3.94% | 97,729 | 7.49M |
| 297 | TARA | Protara Therapeutics, Inc. | 214.70M | -3.05% | 351,326 | - |
| 298 | RNAC | Cartesian Therapeutics, Inc. | 214.49M | -4.58% | 72,669 | 1.78M |
| 299 | CNXU | Conexeu Sciences Inc. | 214.07M | 2.70% | 68,977 | - |
| 300 | CGEN | Compugen Ltd. | 211.87M | -0.88% | 100,845 | 72.66M |
| 301 | CLLS | Cellectis S.A. | 207.98M | 2.29% | 4,887 | 75.11M |
| 302 | KROS | Keros Therapeutics, Inc. | 198.51M | -0.40% | 55,817 | 33.18M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 197.38M | -0.27% | 470,200 | 7.15M |
| 304 | GLSI | Greenwich LifeSciences, Inc. | 194.78M | -1.34% | 51,886 | - |
| 305 | NERV | Minerva Neurosciences, Inc. | 193.81M | -2.80% | 54,459 | - |
| 306 | RNA | Atrium Therapeutics, Inc. | 193.29M | -1.65% | 38,295 | 36.68M |
| 307 | PYXS | Pyxis Oncology, Inc. | 191.33M | 3.78% | 566,973 | 13.86M |
| 308 | NBP | NovaBridge Biosciences | 190.24M | -6.00% | 190,576 | - |
| 309 | ACOG | Alpha Cognition Inc. | 186.65M | 1.93% | 11,958 | 10.83M |
| 310 | MDWD | MediWound Ltd. | 186.04M | -0.99% | 28,625 | 14.48M |
| 311 | VYGR | Voyager Therapeutics, Inc. | 183.98M | 0.16% | 292,436 | 36.49M |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 182.02M | -3.04% | 387,424 | 76.38M |
| 313 | ANTX | AN2 Therapeutics, Inc. | 177.92M | 5.11% | 81,716 | - |
| 314 | LENZ | LENZ Therapeutics, Inc. | 177.78M | -3.57% | 261,640 | 20.99M |
| 315 | OTLK | Outlook Therapeutics, Inc. | 176.81M | 4.59% | 23,405,804 | 333.14K |
| 316 | CAMP | Camp4 Therapeutics Corporation | 176.29M | -0.73% | 27,744 | 3.93M |
| 317 | DTIL | Precision BioSciences, Inc. | 175.46M | -5.16% | 179,795 | 45.07M |
| 318 | IMUX | Immunic, Inc. | 175.31M | -3.52% | 56,812 | - |
| 319 | ARMP | Armata Pharmaceuticals, Inc. | 175.29M | 0.95% | 77,156 | 5.20M |
| 320 | MENS | Jyong Biotech Ltd. | 174.45M | -1.67% | 33,864 | - |
| 321 | IPHA | Innate Pharma S.A. | 171.23M | - | 167 | 10.57M |
| 322 | NGEN | NervGen Pharma Corp. | 170.79M | -0.31% | 163,383 | - |
| 323 | ALEC | Alector, Inc. | 169.87M | 0.66% | 137,390 | 18.42M |
| 324 | HUMA | Humacyte, Inc. | 168.55M | -0.89% | 2,778,991 | 2.02M |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 167.68M | -0.39% | 154,672 | - |
| 326 | ORMP | Oramed Pharmaceuticals Inc. | 166.16M | -2.64% | 65,754 | 2.00M |
| 327 | IVVD | Invivyd, Inc. | 163.68M | -6.35% | 1,458,101 | 55.87M |
| 328 | ARCT | Arcturus Therapeutics Holdings Inc. | 161.16M | -1.39% | 133,541 | 54.71M |
| 329 | OKUR | OnKure Therapeutics, Inc. | 161.09M | 0.95% | 37,809 | - |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 159.39M | -2.86% | 992,814 | 225.00K |
| 331 | KPTI | Karyopharm Therapeutics Inc. | 157.05M | -2.26% | 183,736 | 151.12M |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 154.57M | -6.14% | 203,390 | - |
| 333 | TNXP | Tonix Pharmaceuticals Holding Corp. | 154.47M | -2.52% | 257,076 | 17.56M |
| 334 | NKTX | Nkarta, Inc. | 153.82M | -3.15% | 416,772 | - |
| 335 | ENTX | Entera Bio Ltd. | 153.79M | -4.29% | 995,999 | 42.00K |
| 336 | YDES | YD Bio Limited | 151.19M | -6.52% | 7,971 | 510.36K |
| 337 | MOLN | Molecular Partners AG | 148.64M | - | 86 | 856.30K |
| 338 | CNTN | Canton Strategic Holdings, Inc. | 147.30M | -6.37% | 849,868 | - |
| 339 | KRRO | Korro Bio, Inc. | 146.68M | -3.14% | 72,499 | 3.84M |
| 340 | CBUS | Cibus, Inc. | 146.56M | -1.03% | 134,847 | 4.29M |
| 341 | MIST | Milestone Pharmaceuticals Inc. | 144.21M | -0.93% | 1,443,242 | 1.78M |
| 342 | KZIA | Kazia Therapeutics Limited | 144.21M | -0.55% | 85,765 | 1.27M |
| 343 | CRBU | Caribou Biosciences, Inc. | 143.81M | -2.68% | 694,741 | 11.20M |
| 344 | NAUT | Nautilus Biotechnology, Inc. | 142.53M | -6.67% | 780,569 | 190.00K |
| 345 | EQ | Equillium, Inc. | 142.26M | -3.02% | 204,581 | 4.39M |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 139.14M | -6.21% | 529,859 | 2.29M |
| 347 | CDXS | Codexis, Inc. | 136.34M | - | 355,172 | 78.09M |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 132.31M | -2.23% | 528,104 | - |
| 349 | AARD | Aardvark Therapeutics, Inc. | 130.13M | -7.09% | 89,536 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 129.71M | -0.96% | 99,214 | 233.00K |
| 351 | TLSA | Tiziana Life Sciences Ltd | 129.29M | 3.38% | 43,158 | - |
| 352 | HURA | TuHURA Biosciences, Inc. | 129.28M | -4.69% | 103,256 | - |
| 353 | GNLX | Genelux Corporation | 127.01M | -2.05% | 84,754 | 8.00K |
| 354 | CUE | Cue Biopharma, Inc. | 122.82M | -3.34% | 52,339 | 32.73M |
| 355 | PMN | ProMIS Neurosciences, Inc. | 121.33M | -6.82% | 162,478 | - |
| 356 | ENGN | enGene Therapeutics Inc. | 119.91M | 1.70% | 237,032 | - |
| 357 | PEPG | PepGen Inc. | 118.97M | -6.01% | 478,628 | - |
| 358 | ANIX | Anixa Biosciences, Inc. | 117.04M | -2.27% | 115,177 | - |
| 359 | SEER | Seer, Inc. | 114.64M | -2.57% | 1,541,322 | 15.17M |
| 360 | SPRB | Spruce Biosciences, Inc. | 112.88M | -1.41% | 22,591 | 697.00K |
| 361 | FBIO | Fortress Biotech, Inc. | 111.62M | -0.88% | 209,778 | 66.16M |
| 362 | VANI | Vivani Medical, Inc. | 111.24M | -1.53% | 38,534 | - |
| 363 | GUTS | Fractyl Health, Inc. | 111.18M | -3.02% | 833,298 | 3.00K |
| 364 | RANI | Rani Therapeutics Holdings, Inc. | 102.05M | 0.54% | 284,289 | 3.17M |
| 365 | ICCC | ImmuCell Corporation | 99.51M | -2.14% | 22,755 | 29.93M |
| 366 | ALDX | Aldeyra Therapeutics, Inc. | 95.61M | 0.32% | 412,207 | - |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 94.55M | -6.25% | 454,220 | 70.00M |
| 368 | GOSS | Gossamer Bio, Inc. | 94.25M | -6.00% | 18,620,603 | 55.54M |
| 369 | COYA | Coya Therapeutics, Inc. | 93.95M | 0.12% | 62,842 | 7.94M |
| 370 | HRTX | Heron Therapeutics, Inc. | 92.80M | 0.91% | 515,533 | 150.71M |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 92.42M | -0.37% | 3,842 | 37.16M |
| 372 | PTHS | Pelthos Therapeutics Inc. | 91.34M | -5.37% | 68,120 | 27.70M |
| 373 | NTHI | NeOnc Technologies Holdings, Inc. | 90.77M | 0.29% | 8,968 | 39.99K |
| 374 | PLYX | Polaryx Therapeutics, Inc. | 90.43M | -4.02% | 21,266 | - |
| 375 | ONCY | Oncolytics Biotech Inc. | 89.95M | -4.86% | 661,007 | - |
| 376 | BMEA | Biomea Fusion, Inc. | 89.65M | -0.80% | 218,186 | - |
| 377 | ACET | Adicet Bio, Inc. | 86.21M | 0.12% | 64,935 | - |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 85.56M | 0.97% | 919,216 | 65.34K |
| 379 | OKYO | OKYO Pharma Limited | 85.02M | -1.22% | 114,333 | - |
| 380 | RLYB | Rallybio Corporation | 84.82M | -0.90% | 11,695 | 858.00K |
| 381 | YARW | Yarrow Bioscience, Inc. | 84.35M | 7.40% | 9,418 | - |
| 382 | KLRS | Kalaris Therapeutics, Inc. | 81.61M | 2.69% | 58,960 | - |
| 383 | CGTX | Cognition Therapeutics, Inc. | 78.76M | -4.71% | 219,480 | - |
| 384 | TELO | Telomir Pharmaceuticals, Inc. | 78.40M | -3.39% | 65,690 | - |
| 385 | CSBR | Champions Oncology, Inc. | 77.53M | 0.90% | 4,222 | 59.43M |
| 386 | ATHE | Alterity Therapeutics Limited | 77.40M | -2.52% | 1,217 | 4.43M |
| 387 | PYPD | PolyPid Ltd. | 77.08M | 7.20% | 339,832 | - |
| 388 | NRXS | NeurAxis, Inc. | 76.92M | -4.89% | 92,369 | 4.28M |
| 389 | ALPS | Alps Group Inc | 75.79M | -2.14% | 825 | 3.74M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 72.96M | -3.23% | 340,072 | - |
| 391 | ANVS | Annovis Bio, Inc. | 72.96M | 1.48% | 402,455 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 72.73M | -1.45% | 434,148 | - |
| 393 | ATRA | Atara Biotherapeutics, Inc. | 71.18M | 1.15% | 29,465 | 23.14M |
| 394 | RNTX | Rein Therapeutics Inc. | 70.85M | -2.60% | 154,845 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 68.61M | -0.84% | 487,996 | 61.19M |
| 396 | XBIT | XBiotech Inc. | 68.60M | -0.88% | 29,113 | - |
| 397 | ELTX | Elicio Therapeutics, Inc. | 67.78M | -2.03% | 159,794 | - |
| 398 | LONA | LeonaBio, Inc. | 67.63M | 3.30% | 9,930 | - |
| 399 | PLRX | Pliant Therapeutics, Inc. | 66.25M | - | 130,074 | - |
| 400 | IBIO | iBio, Inc. | 65.82M | -4.68% | 316,390 | 300.00K |
| 401 | OSTX | OS Therapies Incorporated | 65.52M | -1.93% | 170,137 | - |
| 402 | MNOV | MediciNova, Inc. | 63.74M | -2.63% | 7,926 | 596.64K |
| 403 | IMA | ImageneBio, Inc. | 63.61M | -2.08% | 23,362 | 800.00K |
| 404 | HYFT | MindWalk Holdings Corp. | 63.06M | -0.74% | 90,550 | 11.43M |
| 405 | CING | Cingulate Inc. | 61.28M | 0.44% | 94,405 | - |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 60.78M | -7.79% | 494,644 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 57.60M | -1.82% | 106,272 | - |
| 408 | BOLD | Boundless Bio, Inc. | 55.93M | 0.81% | 28,141 | - |
| 409 | CRDF | Cardiff Oncology, Inc. | 54.67M | -2.25% | 753,617 | 525.00K |
| 410 | CNTX | Context Therapeutics Inc. | 54.34M | 0.14% | 547,883 | - |
| 411 | XLO | Xilio Therapeutics, Inc. | 53.85M | -1.64% | 4,263 | 53.48M |
| 412 | INKT | MiNK Therapeutics, Inc. | 51.81M | -1.33% | 3,940 | - |
| 413 | MREO | Mereo BioPharma Group plc | 51.08M | 3.43% | 463,061 | 500.00K |
| 414 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.86M | -1.64% | 47,903 | - |
| 415 | VRXA | Veraxa Biotech AG | 50.69M | 1.52% | 136,912 | - |
| 416 | DWTX | Dogwood Therapeutics, Inc. | 49.44M | -5.16% | 41,245 | - |
| 417 | TIL | Instil Bio, Inc. | 49.17M | -0.55% | 1,799 | - |
| 418 | TCRX | TScan Therapeutics, Inc. | 48.48M | -4.15% | 355,297 | 9.14M |
| 419 | IMMP | Immutep Limited | 48.33M | -0.65% | 58,129 | 5.28M |
| 420 | ATYR | aTyr Pharma, Inc. | 47.52M | -1.90% | 286,619 | 190.00K |
| 421 | BYSI | BeyondSpring Inc. | 47.29M | -2.95% | 4,537 | 1.88M |
| 422 | IBO | Impact BioMedical Inc. | 46.36M | - | 5,960 | 39.00K |
| 423 | INMB | INmune Bio Inc. | 45.99M | 1.17% | 144,973 | 50.00K |
| 424 | MCRB | Seres Therapeutics, Inc. | 45.81M | -1.46% | 33,073 | 1.15M |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | - | 15,037 | 22.33M |
| 426 | FLNA | Filana Therapeutics, Inc. | 42.00M | -1.74% | 144,732 | - |
| 427 | EDSA | Edesa Biotech, Inc. | 41.84M | -5.33% | 83,910 | - |
| 428 | RADX | Radiopharm Theranostics Limited | 41.12M | -6.34% | 41,300 | 10.86M |
| 429 | RNXT | RenovoRx, Inc. | 40.25M | -1.64% | 69,507 | 1.49M |
| 430 | DYAI | Dyadic International, Inc. | 39.72M | 2.83% | 50,274 | 3.81M |
| 431 | APLM | Apollomics, Inc. | 39.49M | -1.32% | 7,831 | 8.84M |
| 432 | EXOZ | eXoZymes, Inc. | 37.31M | - | 3,274 | -700.00 |
| 433 | PDSB | PDS Biotechnology Corporation | 36.80M | -4.54% | 63,913 | - |
| 434 | HYPD | Hyperion DeFi, Inc. | 36.38M | -0.83% | 295,492 | 1.04M |
| 435 | GNTA | Genenta Science S.p.A. | 35.86M | -3.18% | 67,026 | - |
| 436 | NNVC | NanoViricides, Inc. | 35.65M | -2.80% | 80,349 | - |
| 437 | VERU | Veru Inc. | 35.38M | -1.15% | 116,012 | 16.89M |
| 438 | NTRB | Nutriband Inc. | 35.27M | -1.82% | 2,676 | 1.80M |
| 439 | GRCE | Grace Therapeutics, Inc. | 34.50M | -5.78% | 261,172 | - |
| 440 | ENLV | Enlivex Ltd. | 34.07M | -5.36% | 291,103 | - |
| 441 | CRVO | CervoMed Inc. | 33.68M | -2.73% | 142,049 | 2.09M |
| 442 | LTRN | Lantern Pharma Inc. | 33.30M | 0.38% | 15,010 | - |
| 443 | LITS | Lite Strategy, Inc. | 32.36M | -1.94% | 55,720 | - |
| 444 | ESLA | Estrella Immunopharma, Inc. | 32.06M | -0.47% | 766 | - |
| 445 | SER | Serina Therapeutics, Inc. | 31.49M | 1.45% | 3,997 | 130.00K |
| 446 | BCTX | BriaCell Therapeutics Corp. | 30.01M | 0.58% | 36,230 | - |
| 447 | KYNB | Kyntra Bio, Inc. | 28.13M | -0.36% | 867 | 7.44M |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 26.42M | -2.83% | 49,343 | 90.00K |
| 449 | ALGS | Aligos Therapeutics, Inc. | 26.24M | -0.24% | 24,770 | 4.71M |
| 450 | ABVC | ABVC BioPharma, Inc. | 26.03M | -2.84% | 27,208 | 797.92K |
| 451 | ACTU | Actuate Therapeutics, Inc. | 25.60M | 0.94% | 39,388 | - |
| 452 | PSTV | Plus Therapeutics, Inc. | 24.81M | -4.13% | 74,596 | 5.18M |
| 453 | TVGN | Tevogen Bio Holdings Inc. | 24.51M | 3.94% | 8,429 | - |
| 454 | IGC | IGC Pharma, Inc. | 24.42M | -5.79% | 812,345 | 1.11M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 23.99M | 3.05% | 14,082 | 14.97M |
| 456 | EVAX | Evaxion A/S | 23.35M | - | 7,689 | 7.53M |
| 457 | HOWL | Werewolf Therapeutics, Inc. | 23.11M | 5.85% | 731,801 | 1.14M |
| 458 | TVRD | Tvardi Therapeutics, Inc. | 22.28M | -2.66% | 176,676 | - |
| 459 | SKYE | Skye Bioscience, Inc. | 21.51M | -0.45% | 77,586 | - |
| 460 | QNCX | Quince Therapeutics, Inc. | 21.31M | 12.49% | 43,338 | - |
| 461 | PLRZ | Polyrizon Ltd. | 21.25M | 0.80% | 42,919 | - |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 20.81M | 1.05% | 69,471 | -13.27K |
| 463 | CLRB | Cellectar Biosciences, Inc. | 20.57M | 2.98% | 77,393 | - |
| 464 | CVM | CEL-SCI Corporation | 20.27M | -3.33% | 90,651 | - |
| 465 | ATOS | Atossa Therapeutics, Inc. | 19.98M | -3.93% | 23,485 | - |
| 466 | CELU | Celularity Inc. | 19.39M | -11.87% | 232,673 | 26.55M |
| 467 | MRKR | Marker Therapeutics, Inc. | 19.34M | -1.69% | 25,027 | 3.55M |
| 468 | NCEL | NewcelX Ltd. | 19.02M | 1.51% | 6,748 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 18.98M | -4.67% | 77,706 | - |
| 470 | ALLR | Allarity Therapeutics, Inc. | 18.89M | 0.63% | 41,336 | 345.00K |
| 471 | LGVN | Longeveron Inc. | 18.77M | -1.21% | 95,724 | 1.22M |
| 472 | GRDX | GridAI Technologies Corp. | 18.36M | -7.69% | 51,549 | - |
| 473 | NXTC | NextCure, Inc. | 18.10M | -7.56% | 144,757 | - |
| 474 | DARE | Daré Bioscience, Inc. | 17.90M | 0.84% | 37,540 | 1.16M |
| 475 | JSPR | Jasper Therapeutics, Inc. | 17.81M | 0.51% | 64,983 | - |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 17.67M | -10.44% | 440,971 | - |
| 477 | PLUR | Pluri Inc. | 17.59M | -2.98% | 5,485 | 1.08M |
| 478 | LPCN | Lipocine Inc. | 17.15M | -2.80% | 23,354 | 2.00M |
| 479 | PTN | Palatin Technologies, Inc. | 17.10M | 3.52% | 7,828 | 12.88M |
| 480 | OSRH | OSR Health, Inc. | 17.07M | 6.48% | 408,265 | 2.63M |
| 481 | BIOT | Instinct Brothers Co., Ltd. | 15.29M | -60.11% | 4,973,649 | - |
| 482 | CTXR | Citius Pharmaceuticals, Inc. | 15.24M | 11.45% | 490,273 | 5.61M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 15.04M | - | 185,051 | - |
| 484 | MLEC | Moolec Science SA | 14.98M | -0.89% | 964 | 7.83M |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 14.80M | -0.29% | 2,296 | 1.99M |
| 486 | HIND | Vyome Holdings, Inc. | 14.32M | 2.51% | 1,159 | 152.72K |
| 487 | PASG | Passage Bio, Inc. | 14.13M | -3.61% | 4,319 | - |
| 488 | AKTX | Akari Therapeutics, Plc | 14.06M | -4.74% | 1,037 | - |
| 489 | ICU | SeaStar Medical Holding Corporation | 13.49M | -2.47% | 37,017 | 1.44M |
| 490 | LEXX | Lexaria Bioscience Corp. | 12.89M | -3.70% | 54,664 | 194.00K |
| 491 | BLRX | BioLineRx Ltd. | 12.89M | 2.85% | 1,374 | 1.40M |
| 492 | TPST | Tempest Therapeutics, Inc. | 12.73M | -1.26% | 138,027 | - |
| 493 | KALA | KALA BIO, Inc. | 12.18M | -0.79% | 27,763 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 12.13M | -5.87% | 53,898 | 225.00K |
| 495 | INTS | Intensity Therapeutics, Inc. | 12.05M | -1.98% | 6,658 | - |
| 496 | CALC | CalciMedica, Inc. | 12.00M | 5.84% | 241,356 | - |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 11.45M | -2.46% | 54,970 | - |
| 498 | XCUR | Exicure, Inc. | 11.35M | 2.30% | 13,843 | 500.00K |
| 499 | KPRX | Kiora Pharmaceuticals, Inc. | 11.30M | -0.78% | 2,150 | 20.00K |
| 500 | PBM | Psyence Biomedical Ltd. | 11.25M | -6.64% | 10,531 | - |